R
Retina and Eye Consultants | Hurstville, Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
APL-2
Faricimab
Dexamethasone
Pegcetacoplan
IBE-814
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...
Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)
This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.
Enrolling
Diabetic Macular Edema
Drug: Faricimab
Trial sponsors
A
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems